To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene TOMM70ATABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
493 supporting clones for gene TOMM70A back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BI461333 testis .a 1 to 850 1 to 853   tiling clone,   853/993
(85 %)
6 diff
(99.4 %id)
BQ227294 melanotic melanoma, skin .a 167 to 675 1 to 516       516/957
(53 %)
13 diff
(98.7 %id)
CD244562 testis .a 184 to 632 1 to 454       454/969
(46 %)
16 diff
(98.4 %id)
CN362286 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 185 to 874 1 to 690       690/690
(100 %)
3 diff
(99.6 %id)
BC065555 Testis, embryonal carcinoma .a 187 to 4561 1 to 4372 G27T T28A A29G G30P P31G ... available from MGC, AAA   4372/4372
(100 %)
1 diff
(100.0 %id)
BQ223595 embryonal carcinoma, cell line, testis .a 188 to 959 1 to 772   available from MGC,   772/863
(89 %)
9 diff
(99.0 %id)
BI560798 testis .a 200 to 660 1 to 467       467/796
(58 %)
13 diff
(98.4 %id)
TI_44349203   .a 200 to 660 86 to 552       467/881
(53 %)
13 diff
(98.6 %id)
BC052994 Skin, melanotic melanoma. .a 204 to 2724 1 to 2521 exact tiling clone, available from MGC, AAA   2521/2521
(100 %)
0 diff
(100 %id)
BM550770 melanotic melanoma, skin .a 204 to 931 1 to 736       736/1243
(59 %)
17 diff
(98.7 %id)
NM_014820.3   .a 204 to 4561 1 to 4358 exact RefSeq, AAA   4358/4358
(100 %)
0 diff
(100 %id)
BE743929 adenocarcinoma cell line, ovary .a 239 to 1033 1 to 791       791/882
(89 %)
8 diff
(99.1 %id)
BU431645 lymph .a 437 to 795 1 to 359       359/359
(100 %)
3 diff
(99.2 %id)
TI_154153587   .a 444 to 958 80 to 595       516/609
(84 %)
19 diff
(96.9 %id)
BM151806 leukopheresis .a 480 to 993 1 to 514       514/514
(100 %)
6 diff
(98.9 %id)
BI765688 pooled colon, kidney, stomach .a 481 to 1226 32 to 788       757/788
(96 %)
18 diff
(97.8 %id)
TI_57146683   .a 481 to 1226 32 to 788       757/788
(96 %)
18 diff
(97.8 %id)
CN362279 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 482 to 1051 35 to 604       570/604
(94 %)
6 diff
(99.1 %id)
DB471704 hippocampus .a 483 to 959 1 to 477       477/493
(96 %)
3 diff
(99.4 %id)
BM472110 melanotic melanoma, skin .a 483 to 1037 76 to 632       557/1331
(41 %)
18 diff
(98.7 %id)
CX760307 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 511 to 1133 1 to 623     Submitted on the opposite strand 623/742
(83 %)
18 diff
(97.6 %id)
DB466711 hippocampus .a 518 to 953 1 to 436       436/436
(100 %)
2 diff
(99.6 %id)
DB470094 hippocampus .a 518 to 958 1 to 438       438/438
(100 %)
8 diff
(98.2 %id)
BI833895 pooled pancreas and spleen .a 518 to 1165 1 to 650       650/650
(100 %)
2 diff
(99.7 %id)
TI_57166988   .a 518 to 1165 37 to 686       650/686
(94 %)
6 diff
(99.2 %id)
BG387445 embryonal carcinoma, cell line, testis .a 519 to 999 1 to 491       488/1023
(47 %)
30 diff
(97.1 %id)
TI_57242000   .a 519 to 1349 28 to 860   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 833/863
(96 %)
14 diff
(98.4 %id)
CF135900 lymph .a 520 to 1235 1 to 716       716/716
(100 %)
6 diff
(99.2 %id)
BI914924 brain .a 520 to 1349 1 to 832       832/835
(99 %)
9 diff
(99.0 %id)
BC003633 Uterus, endometrium adenocarcinoma .a 521 to 2731 1 to 2211 exact available from MGC, AAA   2211/2211
(100 %)
0 diff
(100 %id)
BY797093 eye .a 521 to 1171 1 to 651       651/651
(100 %)
0 diff
(100 %id)
BU155616 melanotic melanoma, skin .a 522 to 1263 1 to 744       744/933
(79 %)
7 diff
(99.3 %id)
BX437946 neuroblastoma .a 525 to 1388 1 to 860       860/942
(91 %)
20 diff
(97.9 %id)
TI_154164555   .a 526 to 1258 76 to 807       732/912
(80 %)
5 diff
(99.5 %id)
DN997265 breast cancer, Mammary gland (cancer tissue) .a 528 to 1246 8 to 726       719/726
(99 %)
7 diff
(99.1 %id)
BE390905 endometrium, adenocarcinoma cell line, uterus .a 540 to 1194 1 to 660       660/672
(98 %)
28 diff
(95.9 %id)
AB018262 brain .a 545 to 4561 1 to 4017 exact tiling clone, available from KIAA,   4017/4017
(100 %)
0 diff
(100 %id)
BU164797 eye, retinoblastoma .a 555 to 1370 1 to 816       816/844
(96 %)
5 diff
(99.5 %id)
BG766836 melanotic melanoma, high MDR (cell line), skin .a 557 to 1228 1 to 678       676/679
(99 %)
13 diff
(98.1 %id)
BI764122 pooled colon, kidney, stomach .a 557 to 1257 1 to 703       703/713
(98 %)
8 diff
(98.9 %id)
TI_57146617   .a 557 to 1257 70 to 772       703/782
(89 %)
11 diff
(98.6 %id)
BM449461 eye, retinoblastoma .a 560 to 1426 1 to 874       874/947
(92 %)
13 diff
(98.7 %id)
BQ433776 large cell carcinoma, lung .a 560 to 1364 10 to 820       811/884
(91 %)
15 diff
(98.4 %id)
BQ226618 melanotic melanoma, skin .a 563 to 1133 1 to 573       573/997
(57 %)
24 diff
(97.6 %id)
CN362278 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 577 to 1169 1 to 593       593/593
(100 %)
1 diff
(99.9 %id)
BM470626 eye, retinoblastoma .a 590 to 1371 13 to 801       789/961
(82 %)
17 diff
(98.3 %id)
BE892303 melanotic melanoma, skin .a 592 to 1379 1 to 788       785/1096
(71 %)
21 diff
(98.1 %id)
BE869764 adenocarcinoma, colon .a 603 to 1263 1 to 655       655/908
(72 %)
16 diff
(98.3 %id)
TI_1948216165   .a 631 to 1518 132 to 1019       888/1301
(68 %)
34 diff
(97.4 %id)
TI_1948216321   .a 631 to 1519 133 to 1019       887/1345
(65 %)
24 diff
(98.3 %id)
TI_1948216485   .a 631 to 1519 129 to 1011       883/1321
(66 %)
23 diff
(98.3 %id)
TI_1948216638   .a 631 to 1519 131 to 1021       891/1342
(66 %)
23 diff
(98.3 %id)
EL735090 mixed .a 636 to 1293 1 to 654       654/665
(98 %)
4 diff
(99.4 %id)
BF761369 colon_est .a 815 to 1258 460 to 17     Submitted on the opposite strand 444/464
(95 %)
6 diff
(98.8 %id)
BF229820 colon_est .a 823 to 1247 25 to 446       422/446
(94 %)
7 diff
(98.5 %id)
CD557046 brain, Pituitary .a 893 to 1519 12 to 642       633/980
(64 %)
18 diff
(98.2 %id)
CD519608 White Matter .a 893 to 1684 1 to 798       798/893
(89 %)
7 diff
(99.3 %id)
AA313460 colon .a 923 to 1219 1 to 296       296/296
(100 %)
1 diff
(99.7 %id)
AW957817   .a 924 to 1564 1 to 643       643/643
(100 %)
10 diff
(98.5 %id)
AW957894   .a 924 to 1527 1 to 605       605/675
(89 %)
12 diff
(98.3 %id)
DB149675 thymus .a 992 to 1554 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
BI480789 Native Retinal Pigment Epithelium sheets, retina .a 995 to 1542 12 to 570       559/571
(97 %)
25 diff
(95.7 %id)
DA272357 caudate nucleus .a 1011 to 1579 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
BQ888724 dorsal root ganglia .a 1049 to 1862 1 to 815       815/887
(91 %)
3 diff
(99.7 %id)
BF798002 lymph, lymphoma, cell line .a 1060 to 1804 27 to 769       741/977
(75 %)
29 diff
(97.1 %id)
CF137459 lymph .a 1071 to 1461 1 to 391       391/391
(100 %)
24 diff
(93.9 %id)
TI_154166968   .a 1078 to 1519 80 to 521       442/475
(93 %)
30 diff
(93.7 %id)
BX646271   .a 1101 to 1720 1 to 620       620/620
(100 %)
1 diff
(99.9 %id)
BE503487 pooled germ cell tumors .a 1117 to 1355 239 to 1       239/239
(100 %)
2 diff
(99.2 %id)
DB174444 kidney, tumor tissue .a 1131 to 1698 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
CN362280 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1139 to 1878 1 to 740       740/740
(100 %)
0 diff
(100 %id)
AA449405   .a 1160 to 1474 1 to 315       315/315
(100 %)
1 diff
(99.7 %id)
CF144510 CNCAP(3)T-225 cell line, Prostate .a 1173 to 1531 8 to 366       359/366
(98 %)
13 diff
(96.5 %id)
TI_154176536   .a 1173 to 1718 81 to 626       546/549
(99 %)
11 diff
(98.0 %id)
CN362288 embryonic stem cells, cell lines H1, H7, andH9 .a 1180 to 1752 1 to 573       573/573
(100 %)
4 diff
(99.4 %id)
BX498836 Liver .a 1194 to 1692 1 to 499       499/499
(100 %)
1 diff
(99.8 %id)
DA457882 tongue, tumor tissue .a 1201 to 1774 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
BG251357 adenocarcinoma, cell line, Liver .a 1206 to 1897 1 to 689       689/887
(77 %)
4 diff
(99.6 %id)
BM505726 insulinoma, Pancreas .a 1209 to 1794 1 to 586       586/586
(100 %)
3 diff
(99.5 %id)
W76094 heart .a 1209 to 1692 1 to 487       487/487
(100 %)
6 diff
(98.8 %id)
CK905306 insulinoma, Pancreas .a 1209 to 1765 1 to 557       557/564
(98 %)
9 diff
(98.5 %id)
DA368314 subthalamic nucleus .a 1220 to 1778 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DB244349 uterus, tumor tissue .a 1221 to 1779 2 to 560   capped   559/559
(100 %)
1 diff
(99.9 %id)
BE779136 eye, retinoblastoma .a 1240 to 1863 1 to 624       624/873
(71 %)
1 diff
(99.9 %id)
CB149854 Liver .a 1243 to 1661 1 to 419       419/419
(100 %)
1 diff
(99.8 %id)
BX497969 Liver .a 1244 to 1748 1 to 505       505/505
(100 %)
1 diff
(99.9 %id)
DA115933 cerebellum .a 1255 to 1806 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
BP356256   .a 1272 to 1845 1 to 574       574/574
(100 %)
5 diff
(99.2 %id)
BP356283   .a 1272 to 1852 1 to 581       581/581
(100 %)
0 diff
(100 %id)
BP356355   .a 1272 to 1850 1 to 581       581/581
(100 %)
4 diff
(99.4 %id)
DA802511 brain .a 1300 to 1844 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DA440444 tongue, tumor tissue .a 1301 to 1900 2 to 602   capped   601/601
(100 %)
2 diff
(99.7 %id)
AA076346 Pancreas .a 1304 to 1689 1 to 385       385/385
(100 %)
1 diff
(99.8 %id)
BG035820 adenocarcinoma, cell line, Liver .a 1306 to 2088 1 to 785       785/825
(95 %)
19 diff
(97.7 %id)
EH354127   .a 1318 to 1411 1 to 94       94/99
(94 %)
6 diff
(94.0 %id)
BU172321 melanotic melanoma, skin .a 1339 to 2225 1 to 890       890/891
(99 %)
7 diff
(99.3 %id)
DA778281 brain .a 1350 to 1915 2 to 567   capped   566/566
(100 %)
1 diff
(99.9 %id)
CF137423 lymph .a 1365 to 1532 1 to 166       164/166
(98 %)
6 diff
(96.4 %id)
DA722561   .a 1372 to 1939 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
BU172574 melanotic melanoma, skin .a 1373 to 2183 1 to 812       812/872
(93 %)
3 diff
(99.7 %id)
BE897914 melanotic melanoma, skin .a 1374 to 2044 1 to 664       664/665
(99 %)
11 diff
(98.4 %id)
TI_154166846   .a 1374 to 1916 80 to 622       543/544
(99 %)
11 diff
(98.0 %id)
BM454186 lymph, lymphoma, cell line .a 1379 to 2309 1 to 940       940/1046
(89 %)
17 diff
(98.4 %id)
CN362281 embryonic stem cells, cell lines H1, H7, andH9 .a 1380 to 1491 1 to 112       112/112
(100 %)
0 diff
(100 %id)
BG032640 breast, mammary adenocarcinoma, cell line .a 1381 to 2086 1 to 703       703/972
(72 %)
10 diff
(99.0 %id)
BE073158 breast .a 1390 to 1800 16 to 426       411/426
(96 %)
13 diff
(97.0 %id)
BE073145 breast .a 1393 to 1800 409 to 1     Submitted on the opposite strand 409/409
(100 %)
5 diff
(98.8 %id)
CN362287 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1411 to 2153 1 to 743       743/743
(100 %)
2 diff
(99.8 %id)
DW449369 Liver .a 1413 to 1578 17 to 181   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 165/203
(81 %)
22 diff
(89.2 %id)
DA186098 amygdala .a 1435 to 1985 2 to 553   capped   552/552
(100 %)
1 diff
(99.9 %id)
DA390405 thalamus .a 1437 to 2013 2 to 579   capped   578/578
(100 %)
1 diff
(99.9 %id)
DA724824   .a 1440 to 2009 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
DA507607 brain .a 1442 to 1988 2 to 549   capped   548/548
(100 %)
2 diff
(99.7 %id)
DA126599 cerebellum .a 1529 to 2102 2 to 575   capped   574/574
(100 %)
3 diff
(99.5 %id)
DA152333 amygdala .a 1532 to 2103 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
Z19251 leg muscle, skeletal muscle .a 1535 to 1871 1 to 337       337/337
(100 %)
2 diff
(99.5 %id)
TI_1948216322   .a 1537 to 2461 1058 to 124       935/1161
(80 %)
26 diff
(97.8 %id)
BX482828   .a 1545 to 2023 1 to 479       479/479
(100 %)
0 diff
(100 %id)
CT004090 T-Lymphocytes .a 1551 to 2373 1 to 825       825/825
(100 %)
3 diff
(99.7 %id)
TI_1948216639   .a 1557 to 2461 1035 to 123       913/1161
(78 %)
22 diff
(98.2 %id)
DA597390   .a 1563 to 1862 2 to 301   capped   300/300
(100 %)
0 diff
(100 %id)
DB195636 trachea .a 1565 to 2075 2 to 512   capped   511/511
(100 %)
0 diff
(100 %id)
DA534490 brain .a 1574 to 2153 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
TI_1948216486   .a 1574 to 2461 1007 to 121       887/1133
(78 %)
3 diff
(99.8 %id)
DB081073 testis .a 1574 to 2145 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
AK075102 placenta .a 1577 to 4561 1 to 2985   available from FLJ,   2985/2985
(100 %)
1 diff
(100.0 %id)
TI_1948216166   .a 1577 to 2461 1011 to 121       891/1154
(77 %)
18 diff
(98.5 %id)
DA829195 placenta .a 1578 to 2308 2 to 733   capped   732/834
(87 %)
2 diff
(99.8 %id)
BP238361 Liver .a 1581 to 2149 1 to 569       569/611
(93 %)
29 diff
(95.3 %id)
DB084418 testis .a 1589 to 2155 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
DA265918 caudate nucleus .a 1596 to 2152 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
BF679224 Prostate .a 1598 to 1807 1 to 209       209/209
(100 %)
1 diff
(99.6 %id)
BG117638 adenocarcinoma, cell line, Liver .a 1622 to 2266 1 to 639       639/958
(66 %)
21 diff
(97.9 %id)
EH347111   .a 1628 to 1687 1 to 60       60/60
(100 %)
2 diff
(96.7 %id)
DA531059 brain .a 1686 to 2282 2 to 598   capped   597/597
(100 %)
0 diff
(100 %id)
AK075080 placenta .a 1694 to 4561 1 to 2868   available from FLJ,   2868/2868
(100 %)
3 diff
(99.9 %id)
DA828570 placenta .a 1695 to 2319 2 to 632   capped   631/635
(99 %)
13 diff
(98.0 %id)
BG230901 nasopharynx, normal epithelium .a 1705 to 2012 40 to 347       308/347
(88 %)
6 diff
(98.3 %id)
DA309024 hippocampus .a 1712 to 2282 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
DA043736 bladder .a 1722 to 2295 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
BG163860 hypernephroma, cell line, Kidney .a 1733 to 2513 1 to 776       776/889
(87 %)
17 diff
(98.1 %id)
BM714760 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 1733 to 1862 1 to 130       130/144
(90 %)
0 diff
(100 %id)
BE868957 adenocarcinoma, colon .a 1736 to 2390 1 to 653       653/653
(100 %)
12 diff
(98.2 %id)
BG542069 lung .a 1744 to 1807 1 to 64       64/64
(100 %)
0 diff
(100 %id)
BQ962287 leiomyosarcoma, uterus .a 1746 to 2585 1 to 851       851/923
(92 %)
20 diff
(97.9 %id)
BG388862 embryonal carcinoma, cell line, testis .a 1749 to 2551 1 to 796       796/1072
(74 %)
28 diff
(97.4 %id)
DA152695 amygdala .a 1752 to 2340 2 to 590   capped   589/589
(100 %)
0 diff
(100 %id)
BF855200 prostate_normal .a 1771 to 2203 16 to 447       432/447
(96 %)
9 diff
(98.0 %id)
DA260368 caudate nucleus .a 1802 to 2366 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
BE877956 large cell carcinoma, undifferentiated, lung .a 1843 to 2566 1 to 717       719/964
(74 %)
29 diff
(97.0 %id)
BG164329 hypernephroma, cell line, Kidney .a 1843 to 2546 1 to 694       696/890
(78 %)
20 diff
(97.8 %id)
DA579740   .a 1847 to 2394 2 to 550   capped   549/549
(100 %)
1 diff
(99.9 %id)
DA308267 hippocampus .a 1848 to 2433 2 to 588   capped   587/587
(100 %)
1 diff
(99.9 %id)
BE075028 breast .a 1860 to 2379 7 to 526       520/526
(98 %)
1 diff
(99.9 %id)
AI064868 Liver .a 1863 to 2449 1 to 587       587/587
(100 %)
1 diff
(99.9 %id)
BE075023 breast .a 1864 to 2244 11 to 393       381/393
(96 %)
12 diff
(97.0 %id)
BE075026 breast .a 1866 to 2397 14 to 545       532/545
(97 %)
8 diff
(98.6 %id)
DA782392 brain .a 1868 to 2426 2 to 560   capped   559/559
(100 %)
1 diff
(99.9 %id)
BP312566 mammary gland .a 1868 to 2451 1 to 582       582/582
(100 %)
3 diff
(99.5 %id)
BP312575 mammary gland .a 1868 to 2449 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
CD693355 normal nasopharynx .a 1890 to 2328 23 to 461       439/461
(95 %)
16 diff
(96.6 %id)
AW852201 colon .a 1894 to 2319 1 to 424       424/424
(100 %)
2 diff
(99.6 %id)
BX433918 neuroblastoma .a 1961 to 2740 784 to 1       784/888
(88 %)
11 diff
(98.8 %id)
BM828375 stomach .a 1962 to 2554 1 to 591       591/591
(100 %)
2 diff
(99.7 %id)
AI538687 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .a 2007 to 2564 558 to 1       558/558
(100 %)
9 diff
(98.4 %id)
BE546300 cervical carcinoma cell line, cervix .a 2012 to 2739 1 to 729       729/901
(80 %)
32 diff
(96.5 %id)
DA695075   .a 2015 to 2568 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DA497327 brain .a 2018 to 2606 2 to 590   capped   589/589
(100 %)
2 diff
(99.7 %id)
DA691790   .a 2019 to 2589 2 to 572   capped   571/571
(100 %)
2 diff
(99.7 %id)
CK128699 embryonic stem cell, Embryonic stem cells pooled from H7 ES cellline, passage 22 .a 2044 to 2781 19 to 744       726/839
(86 %)
20 diff
(97.7 %id)
DA730806   .a 2054 to 2823 2 to 769   capped   768/768
(100 %)
3 diff
(99.7 %id)
BU595016 mixed (pool of 40 RNAs) .a 2057 to 2729 1 to 673       673/819
(82 %)
5 diff
(99.4 %id)
AI890545 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 2070 to 2746 678 to 1       678/678
(100 %)
13 diff
(98.1 %id)
BU616604 Cell Line, Chondrosarcoma .a 2071 to 2747 691 to 15   AAA   677/677
(100 %)
0 diff
(100 %id)
BQ006964 Chondrosarcoma, Left Pelvis .a 2086 to 2729 656 to 14   AAA   643/649
(99 %)
3 diff
(99.6 %id)
AW439699 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 2100 to 2731 632 to 1       632/632
(100 %)
8 diff
(98.8 %id)
DA509842 brain .a 2114 to 2698 2 to 587   capped   586/586
(100 %)
3 diff
(99.5 %id)
DA763144 tongue .a 2148 to 2699 2 to 553   capped   552/552
(100 %)
2 diff
(99.7 %id)
AK074951   .a 2158 to 4561 1 to 2404   available from FLJ,   2404/2404
(100 %)
5 diff
(99.8 %id)
DA735999   .a 2159 to 3050 2 to 897   capped   896/896
(100 %)
14 diff
(98.5 %id)
DA582410 lung .a 2161 to 2716 2 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
BP240264 Liver .a 2162 to 2724 1 to 563       563/563
(100 %)
4 diff
(99.3 %id)
BU194699 melanotic melanoma, skin .a 2172 to 3003 1 to 842       842/872
(96 %)
19 diff
(97.9 %id)
CA391427 eye, RPE/choroid .a 2192 to 2676 1 to 485       485/485
(100 %)
1 diff
(99.8 %id)
AI628884 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 2199 to 2747 565 to 19   AAA   547/547
(100 %)
2 diff
(99.7 %id)
AI890859 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 2230 to 2904 676 to 1       676/676
(100 %)
8 diff
(98.9 %id)
BG254061 adenocarcinoma, cell line, Prostate .a 2231 to 2930 1 to 702       702/961
(73 %)
24 diff
(97.6 %id)
AW241402 pooled germ cell tumors .a 2238 to 2747 510 to 1       510/510
(100 %)
12 diff
(97.7 %id)
AW070698 breast, four pooled high-grade tumors, including twoprimary tumors and two metastatic to ovary .a 2241 to 2730 488 to 1       488/488
(100 %)
5 diff
(99.0 %id)
AW852191 colon .a 2246 to 2533 289 to 2       288/290
(99 %)
0 diff
(100 %id)
BE677880 pooled .a 2250 to 2449 208 to 9       200/208
(96 %)
0 diff
(100 %id)
DA866947 Prostate .a 2255 to 2792 2 to 539   capped   538/538
(100 %)
0 diff
(100 %id)
AI962251 pooled germ cell tumors .a 2265 to 2747 484 to 1       484/484
(100 %)
9 diff
(98.2 %id)
BF057808 pooled germ cell tumors .a 2276 to 2747 472 to 1       472/472
(100 %)
0 diff
(100 %id)
FN145049 breast carcinoma .a 2280 to 2372 93 to 1     Submitted on the opposite strand 93/94
(98 %)
0 diff
(100 %id)
BE672376 pooled germ cell tumors .a 2286 to 2747 462 to 1       462/462
(100 %)
0 diff
(100 %id)
AI655998 pooled germ cell tumors .a 2292 to 2747 456 to 1       456/456
(100 %)
2 diff
(99.6 %id)
DA501687 brain .a 2298 to 2860 2 to 563   capped   562/562
(100 %)
3 diff
(99.5 %id)
CB052849 leiomyosarcoma, soft tissue .a 2300 to 2743 465 to 22   AAA   444/453
(98 %)
0 diff
(100 %id)
BJ989942 hepatoblastoma .a 2307 to 2886 22 to 600       579/600
(96 %)
6 diff
(99.0 %id)
AW510467 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 2307 to 2743 437 to 1       437/443
(98 %)
15 diff
(96.7 %id)
AW593934 pooled germ cell tumors .a 2310 to 2747 438 to 1       438/438
(100 %)
0 diff
(100 %id)
W72889 heart .a 2311 to 2729 433 to 14   AAA   420/420
(100 %)
1 diff
(99.8 %id)
AW242743 Kidney .a 2313 to 2746 438 to 4       435/438
(99 %)
0 diff
(100 %id)
CD626187   .a 2316 to 2632 1 to 317       317/323
(98 %)
4 diff
(98.8 %id)
CD626188   .a 2316 to 2623 308 to 2       307/308
(99 %)
0 diff
(100 %id)
BU589638 mixed (pool of 40 RNAs) .a 2316 to 2709 1 to 396       396/944
(41 %)
8 diff
(99.2 %id)
BU933350 mixed (pool of 40 RNAs) .a 2316 to 2730 1 to 415       415/419
(99 %)
3 diff
(99.3 %id)
TI_159714589   .a 2318 to 2743 516 to 91   AAA   426/1030
(41 %)
0 diff
(100 %id)
CN478598 Human Lung Epithelial cells, lung .a 2318 to 2743 444 to 19   AAA   426/435
(97 %)
0 diff
(100 %id)
FN117427 breast carcinoma .a 2320 to 2387 1 to 67       67/71
(94 %)
3 diff
(95.8 %id)
BE502137 pooled germ cell tumors .a 2322 to 2730 409 to 1       409/409
(100 %)
0 diff
(100 %id)
BF592891 pooled germ cell tumors .a 2322 to 2729 432 to 25   AAA   408/408
(100 %)
1 diff
(99.8 %id)
CX751891 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 2323 to 3088 1 to 757     Submitted on the opposite strand 757/796
(95 %)
12 diff
(98.5 %id)
AI913939 colon .a 2329 to 2747 419 to 1       419/419
(100 %)
1 diff
(99.8 %id)
AI766912 2 pooled tumors (clear cell type), Kidney .a 2333 to 2643 311 to 1       311/311
(100 %)
0 diff
(100 %id)
AW206368   .a 2336 to 2747 429 to 18   AAA   412/412
(100 %)
0 diff
(100 %id)
AW242300 Kidney .a 2344 to 2747 409 to 6       404/409
(98 %)
0 diff
(100 %id)
DA792684 brain .a 2357 to 2960 2 to 608   capped   607/607
(100 %)
8 diff
(98.7 %id)
AI370901   .a 2362 to 2729 380 to 13   AAA   368/368
(100 %)
2 diff
(99.5 %id)
CA444214 lung, Metastatic Chondrosarcoma .a 2367 to 2747 395 to 15   AAA   381/381
(100 %)
0 diff
(100 %id)
BE927921 colon .a 2375 to 2975 598 to 2       597/599
(99 %)
0 diff
(100 %id)
AI269861 adenocarcinoma, Pancreas .a 2399 to 2748 350 to 1       350/350
(100 %)
1 diff
(99.8 %id)
AA912859 pooled .a 2400 to 2733 335 to 2       334/335
(99 %)
0 diff
(100 %id)
DA811827 ovary, tumor tissue .a 2401 to 3183 2 to 786   capped   785/789
(99 %)
8 diff
(99.0 %id)
BE927867 colon .a 2403 to 2983 580 to 1       580/580
(100 %)
12 diff
(98.0 %id)
AI440431 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 2405 to 2752 347 to 1       347/347
(100 %)
3 diff
(99.2 %id)
AW874171 follicular carcinoma, thyroid .a 2422 to 2747 341 to 11   AAA   331/333
(99 %)
6 diff
(98.2 %id)
AA449269   .a 2428 to 2746 323 to 5       319/323
(98 %)
0 diff
(100 %id)
CF144506 CNCAP(3)T-225 cell line, Prostate .a 2434 to 2722 1 to 289   AAA   289/289
(100 %)
4 diff
(98.7 %id)
CF144553 CNCAP(3)T-225 cell line, Prostate .a 2434 to 2722 1 to 289   AAA   289/289
(100 %)
4 diff
(98.7 %id)
AI125399   .a 2450 to 2747 312 to 15   AAA   298/298
(100 %)
1 diff
(99.7 %id)
AI962408 pooled germ cell tumors .a 2453 to 2747 316 to 22   AAA   295/295
(100 %)
0 diff
(100 %id)
R82858 placenta .a 2454 to 2866 1 to 422       422/427
(98 %)
14 diff
(96.8 %id)
AI651447 Kidney .a 2455 to 2747 293 to 1       293/293
(100 %)
5 diff
(98.3 %id)
DA827180 pericardium .a 2467 to 2990 2 to 525   capped   524/524
(100 %)
3 diff
(99.5 %id)
AW603030 breast .a 2476 to 2806 345 to 15       331/362
(91 %)
0 diff
(100 %id)
DA072558 cerebellum .a 2492 to 3055 2 to 565   capped   564/567
(99 %)
4 diff
(99.3 %id)
BE927954 colon .a 2497 to 2982 488 to 1       488/488
(100 %)
26 diff
(94.7 %id)
AA322088 brain, cerebellum .a 2505 to 2841 1 to 338       338/338
(100 %)
1 diff
(99.8 %id)
BG391737 embryonal carcinoma, cell line, testis .a 2520 to 3145 1 to 625       625/625
(100 %)
6 diff
(99.1 %id)
DA684497   .a 2534 to 3062 2 to 530   capped   529/529
(100 %)
1 diff
(99.9 %id)
AA564527   .a 2559 to 2692 148 to 16       133/148
(89 %)
0 diff
(100 %id)
BF514420   .a 2580 to 2961 12 to 393     Submitted on the opposite strand 382/393
(97 %)
6 diff
(98.5 %id)
BE535739 cervix .a 2588 to 3154 1 to 565       565/810
(69 %)
10 diff
(98.8 %id)
AV762904 bone marrow .a 2595 to 3132 1 to 532       532/756
(70 %)
33 diff
(95.7 %id)
FN073541 breast carcinoma .a 2635 to 2746 1 to 113       113/113
(100 %)
1 diff
(99.2 %id)
AA369997 Prostate .a 2655 to 2871 1 to 217       217/217
(100 %)
1 diff
(99.6 %id)
AA370398 Prostate .a 2655 to 2965 1 to 315       315/315
(100 %)
9 diff
(97.2 %id)
AW957044   .a 2656 to 3017 1 to 362       362/362
(100 %)
26 diff
(92.9 %id)
DA198647 brain .a 2687 to 3260 2 to 576   capped   575/575
(100 %)
2 diff
(99.7 %id)
BX500530 Liver .a 2691 to 3339 1 to 649       649/649
(100 %)
0 diff
(100 %id)
BX500539 Liver .a 2691 to 3339 1 to 649       649/649
(100 %)
0 diff
(100 %id)
CN362284 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 2695 to 3367 1 to 673       673/673
(100 %)
1 diff
(99.9 %id)
DB174785 kidney, tumor tissue .a 2771 to 3340 2 to 572   capped   571/571
(100 %)
3 diff
(99.5 %id)
R94191 liver and spleen .a 2773 to 3140 2 to 380     Submitted on the opposite strand 379/454
(83 %)
15 diff
(96.7 %id)
CB112386 Liver .a 2773 to 3340 1 to 568       568/568
(100 %)
1 diff
(99.9 %id)
DA603791   .a 2776 to 3291 2 to 518   capped   517/517
(100 %)
1 diff
(99.9 %id)
FN061263 breast carcinoma .a 2794 to 2899 106 to 1     Submitted on the opposite strand 106/106
(100 %)
0 diff
(100 %id)
DA611460   .a 2810 to 3290 2 to 484   capped   483/483
(100 %)
3 diff
(99.4 %id)
BP206230 coronary artery .a 2820 to 3389 1 to 570       570/570
(100 %)
5 diff
(99.2 %id)
D60204   .a 2838 to 3157 1 to 319       319/319
(100 %)
3 diff
(99.1 %id)
D61266   .a 2838 to 3218 1 to 379       379/379
(100 %)
5 diff
(98.7 %id)
D81582 brain .a 2838 to 3124 1 to 287       287/287
(100 %)
1 diff
(99.7 %id)
CX868811 embryonic stem .a 2891 to 3705 1 to 815       815/815
(100 %)
1 diff
(99.9 %id)
BP269250 thyroid .a 2905 to 3484 1 to 581       581/581
(100 %)
2 diff
(99.7 %id)
W06896 lung .a 2929 to 3554 1 to 621       621/621
(100 %)
19 diff
(97.0 %id)
DA569203 whole embryo, mainly head .a 2966 to 3828 2 to 865   capped   864/870
(99 %)
8 diff
(99.1 %id)
DB355812 whole embryo, mainly head .a 3928 to 4561 628 to 1       628/646
(97 %)
13 diff
(98.0 %id)
CX868731 embryonic stem .a 3942 to 4561 648 to 29   AAA   620/620
(100 %)
1 diff
(99.9 %id)
CK905305 insulinoma, Pancreas .a 3964 to 4523 560 to 1       560/560
(100 %)
2 diff
(99.7 %id)
DB371073 ovary, tumor tissue .a 3971 to 4561 583 to 1       583/583
(100 %)
14 diff
(97.6 %id)
BJ989943 hepatoblastoma .a 4001 to 4540 540 to 1       540/540
(100 %)
0 diff
(100 %id)
DB362778   .a 4007 to 4561 556 to 1       556/560
(99 %)
11 diff
(98.1 %id)
DB368410   .a 4035 to 4561 523 to 1       523/525
(99 %)
10 diff
(98.1 %id)
D60203   .a 4094 to 4561 468 to 1       468/468
(100 %)
1 diff
(99.8 %id)
R82859 placenta .a 4186 to 4541 361 to 1       361/361
(100 %)
7 diff
(98.1 %id)
N70890 lung .a 4191 to 4563 376 to 3       374/414
(90 %)
0 diff
(100 %id)
AW576214 lymph .a 4231 to 4561 348 to 18   AAA   331/331
(100 %)
5 diff
(98.5 %id)
DB373915 placenta .a 4286 to 4561 276 to 1       276/276
(100 %)
2 diff
(99.3 %id)
DB373123 placenta .a 4297 to 4561 265 to 1       265/265
(100 %)
0 diff
(100 %id)
DN916956   .b 1 to 650 1 to 643 exact tiling clone,   643/649
(99 %)
12 diff
(98.2 %id)
CA489477   .b 178 to 1049 36 to 912   tiling clone,   877/912
(96 %)
6 diff
(99.4 %id)
CA396591 eye, RPE/choroid .b 506 to 1061 1 to 556   tiling clone,   556/556
(100 %)
0 diff
(100 %id)
AV753014 Pituitary .b 648 to 1065 1 to 417   AAA   417/417
(100 %)
3 diff
(99.3 %id)
DN916955   .b 693 to 1132 440 to 1       440/440
(100 %)
6 diff
(98.7 %id)
AW103807 ovary, tumor, 5 pooled (see description) .b 1026 to 1473 448 to 1   tiling clone,   448/448
(100 %)
6 diff
(98.7 %id)
AI669017 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .b 1071 to 1473 403 to 1   tiling clone,   403/403
(100 %)
0 diff
(100 %id)
AA134420 colon, tumor .b 1155 to 1330 1 to 176   fully sequenced,   176/176
(100 %)
0 diff
(100 %id)
AA134421 colon, tumor .b 1322 to 1667 348 to 1   tiling clone, fully sequenced,   348/348
(100 %)
3 diff
(99.2 %id)
BX508242   .c-u 1 to 458 1 to 458 exact tiling clone,   458/458
(100 %)
0 diff
(100 %id)
AW468485 myeloid cells, 18 pooled CML cases, BCR/ABLrearrangement positive, includes both chronic phase andmyeloid blast crisis, whole blood .d 1 to 458 458 to 1 K43X tiling clone,   458/458
(100 %)
0 diff
(100 %id)
BQ011969 placenta .e 1 to 473 491 to 19 R79S tiling clone, AAA   473/473
(100 %)
2 diff
(99.6 %id)
BQ011757 placenta .e 8 to 473 484 to 19   tiling clone, AAA   466/466
(100 %)
2 diff
(99.6 %id)
AL541698 placenta .f-u 1 to 955 1 to 954   tiling clone,   954/954
(100 %)
3 diff
(99.7 %id)
D60341   .f-u 56 to 505 1 to 449     Submitted on the opposite strand 449/449
(100 %)
2 diff
(99.6 %id)
AA247919   .f-u 176 to 298 1 to 123       123/123
(100 %)
2 diff
(98.4 %id)
BE927027 colon_normal .f-u 320 to 818 1 to 499       499/499
(100 %)
15 diff
(97.0 %id)
DB351822 uterus .f-u 412 to 914 1 to 503   tiling clone, Submitted on the opposite strand 503/503
(100 %)
0 diff
(100 %id)
DB309038 hippocampus .f-u 421 to 941 1 to 521     Submitted on the opposite strand 521/521
(100 %)
2 diff
(99.7 %id)
DB565146.
matches multiple genes
hypothalamus .f-u 423 to 868 447 to 1     also hits gene NIT2 447/447
(100 %)
5 diff
(98.9 %id)
H29863 eye, retina .f-u 423 to 841 1 to 426     Submitted on the opposite strand 426/426
(100 %)
13 diff
(97.0 %id)
R92556 liver and spleen .f-u 1338 to 1715 1 to 384   tiling clone,   384/458
(83 %)
13 diff
(97.2 %id)
DA615943   .f-u 1342 to 1917 2 to 577   tiling clone, capped   576/576
(100 %)
1 diff
(99.9 %id)
R12926 whole brain .f-u 1351 to 1668 1 to 329       329/396
(83 %)
12 diff
(97.0 %id)
CB146505 Liver .f-u 1362 to 2004 1 to 646       646/646
(100 %)
1 diff
(99.9 %id)
CB113180 Liver .f-u 1397 to 1983 1 to 586   tiling clone,   586/586
(100 %)
1 diff
(99.9 %id)
AA676845 liver and spleen .f-u 1408 to 1822 436 to 19       418/436
(95 %)
6 diff
(98.7 %id)
BP259377 heart .f-u 1424 to 1951 1 to 526       526/561
(93 %)
22 diff
(96.1 %id)
BF245042 brain, glioblastoma .f-u 1427 to 2110 1 to 673       673/858
(78 %)
44 diff
(94.9 %id)
AA779146 liver and spleen .f-u 1453 to 1822 391 to 19       373/391
(95 %)
6 diff
(98.5 %id)
BM750513 Ascites, stomach .f-u 1458 to 2004 1 to 547       547/547
(100 %)
1 diff
(99.9 %id)
CR596819 HeLa cells Cot 25-normalized .f-u 1465 to 2919 1 to 1455 exact tiling clone,   1455/1455
(100 %)
0 diff
(100 %id)
AL555758 placenta .f-u 1465 to 2384 1 to 923       923/923
(100 %)
3 diff
(99.7 %id)
T89760 liver and spleen .f-u 1503 to 1970 481 to 1     Submitted on the opposite strand 481/507
(94 %)
16 diff
(96.9 %id)
R19659 whole brain .f-u 1505 to 1852 1 to 349       349/471
(74 %)
2 diff
(99.6 %id)
BF241428 bone marrow, from acute myelogenous leukemia .f-u 1505 to 2032 1 to 543       543/808
(67 %)
33 diff
(96.0 %id)
TI_57199888   .f-u 1511 to 2307 59 to 849       791/850
(93 %)
12 diff
(98.6 %id)
BX091441 whole brain .f-u 1512 to 2047 1 to 536       536/536
(100 %)
3 diff
(99.5 %id)
R60688 whole brain .f-u 1513 to 1985 1 to 476       476/476
(100 %)
11 diff
(97.7 %id)
BI818910 pooled brain, lung, testis .f-u 1515 to 2307 1 to 787       787/788
(99 %)
10 diff
(98.8 %id)
BE738934 hypernephroma, Kidney .f-u 1518 to 2121 1 to 598       598/598
(100 %)
9 diff
(98.5 %id)
AA364574 pineal body .f-u 1519 to 1764 1 to 246       246/246
(100 %)
0 diff
(100 %id)
CF147335 CNCAP(3)T-225 cell line, Prostate .f-u 1556 to 2159 7 to 612       606/612
(99 %)
6 diff
(99.1 %id)
TI_154179951   .f-u 1556 to 2304 78 to 818       741/883
(83 %)
14 diff
(98.5 %id)
BF208647 bladder, carcinoma, cell line .f-u 1558 to 2230 1 to 664       664/861
(77 %)
32 diff
(96.3 %id)
W03592 melanocyte .f-u 1566 to 2003 1 to 434       434/443
(97 %)
9 diff
(98.0 %id)
N50499 multiple sclerosis lesions .f-u 1570 to 1870 1 to 301       301/301
(100 %)
4 diff
(98.7 %id)
CR741478   .f-u 1579 to 1870 1 to 292       292/295
(98 %)
1 diff
(99.7 %id)
R94290 liver and spleen .f-u 1600 to 1970 376 to 1     Submitted on the opposite strand 376/427
(88 %)
7 diff
(98.4 %id)
BM792915 Ascites, stomach .f-u 1614 to 2049 1 to 436       436/436
(100 %)
1 diff
(99.8 %id)
BF667274 brain, primitive neuroectoderm .f-u 1621 to 2228 1 to 608       608/858
(70 %)
9 diff
(99.0 %id)
BF131916 hypernephroma, Kidney .f-u 1672 to 2319 1 to 642       642/856
(75 %)
22 diff
(97.5 %id)
BF339783 brain, glioblastoma with EGFR amplification .f-u 1676 to 2484 1 to 813       813/894
(90 %)
33 diff
(96.4 %id)
BG284095 adenocarcinoma, cell line, Prostate .f-u 1679 to 2466 1 to 790       790/795
(99 %)
9 diff
(98.9 %id)
BG707330 brain, hypothalamus .f-u 1680 to 2432 1 to 752       752/753
(99 %)
8 diff
(99.0 %id)
BF671934 muscle (skeletal) .f-u 1681 to 2333 1 to 646       646/854
(75 %)
12 diff
(98.6 %id)
BG485471 lung .f-u 1683 to 2422 1 to 744       744/927
(80 %)
18 diff
(98.1 %id)
BF126283 Liver .f-u 1686 to 2323 1 to 630       630/630
(100 %)
11 diff
(98.3 %id)
BF238989 bone marrow, from chronic myelogenous leukemia .f-u 1702 to 2392 1 to 672       672/851
(78 %)
24 diff
(97.2 %id)
CA775411 Pancreas, Purified pancreatic islet .f-u 1702 to 2285 7 to 593   fully sequenced,   587/593
(98 %)
6 diff
(99.0 %id)
BF791255 muscle (skeletal) .f-u 1721 to 2381 1 to 652       652/880
(74 %)
15 diff
(98.3 %id)
BG623409 placenta .f-u 1759 to 2454 1 to 703       703/844
(83 %)
9 diff
(99.0 %id)
BM311108 Pancreas, Purified pancreatic islet .f-u 1761 to 2115 1 to 355       355/355
(100 %)
1 diff
(99.8 %id)
BF055228 pooled .f-u 1809 to 2381 573 to 1       573/573
(100 %)
1 diff
(99.9 %id)
BG565884 Liver .f-u 1824 to 2503 1 to 688       688/1031
(66 %)
12 diff
(98.9 %id)
T30739 adrenal gland .f-u 1831 to 2161 1 to 331       331/331
(100 %)
2 diff
(99.4 %id)
BG027184 Bone, osteosarcoma, cell line .f-u 1834 to 2519 1 to 677       677/920
(73 %)
22 diff
(97.7 %id)
AL541697 placenta .f-u 1846 to 2872 1027 to 1 V8X T18R F21X L25X     1027/1027
(100 %)
2 diff
(99.9 %id)
BM857008 stomach .f-u 1846 to 2255 1 to 410       410/410
(100 %)
0 diff
(100 %id)
BF790584 muscle (skeletal) .f-u 1848 to 2583 1 to 725       725/727
(99 %)
42 diff
(94.3 %id)
BG292180 bladder, transitional cell papilloma, cell line .f-u 1855 to 2519 1 to 661       661/957
(69 %)
9 diff
(99.1 %id)
CB962434 Blood vessels - aorta, basilar and artery .f-u 1865 to 2528 1 to 666       666/758
(87 %)
12 diff
(98.5 %id)
DR421688 eye, Pterygium .f-u 1867 to 2384 1 to 519       519/519
(100 %)
7 diff
(98.7 %id)
T32002 uterus .f-u 1879 to 2161 1 to 283       283/283
(100 %)
0 diff
(100 %id)
T32009 uterus .f-u 1879 to 2157 1 to 279       279/279
(100 %)
3 diff
(99.0 %id)
FN076196 breast carcinoma .f-u 1896 to 1998 1 to 100       100/100
(100 %)
3 diff
(97.0 %id)
BG565151 Liver .f-u 1896 to 2485 1 to 614       614/687
(89 %)
12 diff
(98.3 %id)
AL578180 placenta .f-u 1898 to 2852 954 to 1 L57X     954/954
(100 %)
3 diff
(99.7 %id)
BF575354 muscle (skeletal) .f-u 1899 to 2583 1 to 680       680/873
(77 %)
38 diff
(95.7 %id)
N50568 multiple sclerosis lesions .f-u 1902 to 2228 1 to 327       327/327
(100 %)
3 diff
(99.1 %id)
CB148962 Liver .f-u 1909 to 2448 1 to 540       540/540
(100 %)
0 diff
(100 %id)
BI013391 lung_tumor .f-u 1929 to 2088 163 to 6       158/163
(96 %)
0 diff
(100 %id)
BF172575 blood .f-u 1934 to 2310 1 to 381       381/382
(99 %)
8 diff
(98.0 %id)
FN129143 breast carcinoma .f-u 1939 to 2022 1 to 82       82/82
(100 %)
4 diff
(95.2 %id)
CR623762 T cells (Jurkat cell line) Cot10-normalized .f-u 1941 to 2831 1 to 891       891/891
(100 %)
0 diff
(100 %id)
AL580814 T cells from T cell leukemia .f-u 1951 to 2831 880 to 1       880/880
(100 %)
6 diff
(99.4 %id)
Z19250 leg muscle, skeletal muscle .f-u 1955 to 2269 316 to 2       315/316
(99 %)
0 diff
(100 %id)
BG505007 embryonal carcinoma, testis .f-u 1963 to 2543 1 to 603       603/923
(65 %)
45 diff
(95.2 %id)
TI_151770800   .f-u 1972 to 2447 109 to 587       479/1038
(46 %)
12 diff
(98.9 %id)
AA047526 uterus .f-u 1988 to 2423 1 to 453       453/457
(99 %)
6 diff
(98.7 %id)
BE739715 hypernephroma, Kidney .f-u 2000 to 2813 823 to 3       821/931
(88 %)
0 diff
(100 %id)
TI_154029856   .f-u 2001 to 2885 971 to 87 exact AAA   885/958
(92 %)
16 diff
(98.4 %id)
BG504668 embryonal carcinoma, testis .f-u 2009 to 2842 1 to 829       829/835
(99 %)
33 diff
(96.1 %id)
BM697244 eye, fetal eyes .f-u 2023 to 2654 1 to 632   fully sequenced,   632/632
(100 %)
0 diff
(100 %id)
D52213   .f-u 2027 to 2481 462 to 6     Submitted on the opposite strand 457/462
(98 %)
0 diff
(100 %id)
BE960925 melanotic melanoma, high MDR, skin .f-u 2031 to 2722 1 to 669       669/831
(80 %)
28 diff
(96.7 %id)
BF931344 nervous_tumor .f-u 2043 to 2279 1 to 237       237/237
(100 %)
1 diff
(99.6 %id)
BF935534 nervous_tumor .f-u 2043 to 2279 238 to 1     Submitted on the opposite strand 238/238
(100 %)
2 diff
(99.2 %id)
T35682 small intestine .f-u 2043 to 2262 1 to 221       221/221
(100 %)
1 diff
(99.6 %id)
CD679339 eye, Trabecular meshwork .f-u 2045 to 2623 1 to 579       579/579
(100 %)
1 diff
(99.9 %id)
BE091134 breast .f-u 2062 to 2497 21 to 454       434/464
(93 %)
3 diff
(99.4 %id)
BF978997 melanotic melanoma, high MDR, skin .f-u 2071 to 2798 1 to 718       718/849
(84 %)
24 diff
(97.2 %id)
H39632 breast .f-u 2087 to 2536 1 to 455   fully sequenced,   455/455
(100 %)
10 diff
(97.9 %id)
TI_154113567   .f-u 2091 to 2885 821 to 25 I74T L76F L77C AAA   797/997
(79 %)
47 diff
(95.3 %id)
BE086398 breast .f-u 2093 to 2288 206 to 11     Submitted on the opposite strand 196/212
(92 %)
0 diff
(100 %id)
BE175916 head_neck .f-u 2093 to 2275 184 to 3     Submitted on the opposite strand 182/190
(95 %)
0 diff
(100 %id)
AA152134 uterus .f-u 2140 to 2481 20 to 362       343/362
(94 %)
6 diff
(98.4 %id)
CB143703 Liver .f-u 2140 to 2546 1 to 407       407/407
(100 %)
6 diff
(98.6 %id)
EH352147   .f-u 2143 to 2227 1 to 85       85/85
(100 %)
0 diff
(100 %id)
D55592   .f-u 2151 to 2484 331 to 1     Submitted on the opposite strand 331/336
(98 %)
2 diff
(99.5 %id)
BU621930 Cell Line, Chondrosarcoma .f-u 2161 to 2885 744 to 19 exact AAA   726/726
(100 %)
5 diff
(99.4 %id)
TI_151762622   .f-u 2176 to 2886 64 to 774 exact   Submitted on the opposite strand 711/1038
(68 %)
2 diff
(99.9 %id)
C14917   .f-u 2178 to 2484 309 to 1     Submitted on the opposite strand 309/309
(100 %)
2 diff
(99.4 %id)
AW975874   .f-u 2188 to 2884 701 to 1 exact   Submitted on the opposite strand 701/701
(100 %)
12 diff
(98.3 %id)
AW470297 carcinoid, lung .f-u 2208 to 2667 460 to 1       460/460
(100 %)
0 diff
(100 %id)
CN362282 embryonic stem cells, cell lines H1, H7, andH9 .f-u 2210 to 2845 636 to 1 exact   Submitted on the opposite strand 636/636
(100 %)
3 diff
(99.6 %id)
CD356843 Blood vessels - aorta, basilar and artery .f-u 2211 to 2885 1 to 684 P45A F46I Y47L T48Y V49C ...     684/749
(91 %)
17 diff
(97.8 %id)
CA442329 Fibrosarcoma .f-u 2214 to 2885 690 to 19 exact AAA   672/672
(100 %)
3 diff
(99.6 %id)
TI_149310825   .f-u 2223 to 2885 759 to 90   AAA   670/962
(69 %)
23 diff
(97.7 %id)
BX369679   .f-u 2228 to 2885 1 to 663 S23F L25F I30H G32W L33G ...     663/701
(94 %)
33 diff
(95.3 %id)
R82696 placenta .f-u 2231 to 2510 1 to 284       284/456
(62 %)
5 diff
(99.0 %id)
N47394 multiple sclerosis lesions .f-u 2238 to 2476 1 to 239       239/239
(100 %)
2 diff
(99.2 %id)
BF245802 brain, glioblastoma .f-u 2239 to 2886 1 to 649 A13V V14Y F15L T16H L17* AAA   649/649
(100 %)
16 diff
(97.6 %id)
CB998592 Blood vessels - aorta, basilar and artery .f-u 2244 to 2733 1 to 501       501/727
(68 %)
22 diff
(97.0 %id)
BU732921 eye, Retina Foveal and Macular .f-u 2253 to 2885 652 to 19 exact AAA   634/634
(100 %)
4 diff
(99.4 %id)
CA775169 Pancreas, Purified pancreatic islet .f-u 2255 to 2885 631 to 1 exact fully sequenced,   631/631
(100 %)
4 diff
(99.4 %id)
CA438625 lung, Metastatic Chondrosarcoma .f-u 2255 to 2885 651 to 19 exact AAA   633/633
(100 %)
3 diff
(99.6 %id)
BE939004 testis_normal .f-u 2259 to 2697 439 to 2       438/439
(99 %)
0 diff
(100 %id)
R75994 placenta .f-u 2264 to 2607 1 to 344       344/355
(96 %)
1 diff
(99.8 %id)
BE896579 melanotic melanoma, skin .f-u 2265 to 2875 15 to 624 L33W L76F L77C     610/625
(97 %)
6 diff
(99.1 %id)
AW770695 carcinoid, lung .f-u 2270 to 2720 1 to 451     Submitted on the opposite strand 451/451
(100 %)
7 diff
(98.5 %id)
BU621554 cell lines, Chondrosarcoma .f-u 2274 to 2885 632 to 19 exact AAA   614/614
(100 %)
2 diff
(99.7 %id)
BM930066 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .f-u 2276 to 2887 638 to 27 exact   Submitted on the opposite strand 612/638
(95 %)
0 diff
(100 %id)
BE834097 ovary .f-u 2285 to 2709 29 to 453       425/453
(93 %)
6 diff
(98.7 %id)
N49863 multiple sclerosis lesions .f-u 2287 to 2885 602 to 1 Q38R R39K K40E L41T K42E ...     602/602
(100 %)
18 diff
(97.1 %id)
AI769448 2 pooled tumors (clear cell type), Kidney .f-u 2289 to 2885 600 to 4 exact     597/600
(99 %)
0 diff
(100 %id)
BG110911 Bone, osteosarcoma, cell line .f-u 2295 to 2810 1 to 527       527/630
(83 %)
18 diff
(97.2 %id)
BG113042 Bone, osteosarcoma, cell line .f-u 2296 to 2885 1 to 590 E64D T65N A66C L67T K68E ... AAA   590/590
(100 %)
5 diff
(99.2 %id)
BI497105 cochlea, ear .f-u 2303 to 2696 8 to 401       394/401
(98 %)
11 diff
(97.3 %id)
BM505489 insulinoma, Pancreas .f-u 2305 to 2885 594 to 14 exact AAA   581/581
(100 %)
1 diff
(99.9 %id)
BU688999 lung .f-u 2315 to 2885 589 to 19 exact AAA   571/573
(99 %)
2 diff
(99.7 %id)
BF439652 pooled .f-u 2320 to 2884 565 to 1 exact     565/565
(100 %)
0 diff
(100 %id)
FN050569 breast carcinoma .f-u 2323 to 2444 118 to 1     Submitted on the opposite strand 118/121
(97 %)
5 diff
(95.9 %id)
AA535637 invasive prostate tumor, Prostate .f-u 2329 to 2784 1 to 453       453/453
(100 %)
4 diff
(99.2 %id)
AI581514 aorta .f-u 2329 to 2887 560 to 2 exact     559/560
(99 %)
0 diff
(100 %id)
CR745450 multiple sclerosis lesions .f-u 2347 to 2885 1 to 538 F63L AAA   538/538
(100 %)
2 diff
(99.7 %id)
BG118281 adenocarcinoma, cell line, Liver .f-u 2349 to 2887 1 to 537 exact     537/622
(86 %)
5 diff
(99.2 %id)
H11342.
matches multiple genes
whole brain .f-u 2351 to 2887 542 to 7 F46I Y47L T48Y V49C I50H ...   also hits gene SNRNP48 536/542
(98 %)
0 diff
(100 %id)
N78439 multiple sclerosis lesions .f-u 2357 to 2740 1 to 388       388/482
(80 %)
11 diff
(97.8 %id)
BM311701 Pancreas, Purified pancreatic islet .f-u 2359 to 2884 526 to 1 exact     526/526
(100 %)
0 diff
(100 %id)
AI671783 Kidney .f-u 2362 to 2885 524 to 1 exact     524/524
(100 %)
0 diff
(100 %id)
AW471382 adenocarcinoma, Pancreas .f-u 2362 to 2886 525 to 1 exact     525/525
(100 %)
0 diff
(100 %id)
AI795924 Kidney .f-u 2363 to 2888 527 to 2 E36K     526/527
(99 %)
0 diff
(100 %id)
AW044465 Kidney .f-u 2365 to 2891 530 to 4 exact     527/530
(99 %)
0 diff
(100 %id)
BF062612 colon, colon tumor, RER+ .f-u 2365 to 2887 525 to 3 Y47*     523/525
(99 %)
0 diff
(100 %id)
BQ428580 leiomyosarcoma, uterus .f-u 2373 to 2885 1 to 514 exact AAA   514/514
(100 %)
1 diff
(99.9 %id)
BG288930 bladder, transitional cell papilloma, cell line .f-u 2374 to 2850 265 to 736 P58L V59L V60*     472/902
(52 %)
14 diff
(98.5 %id)
AI833063 colon .f-u 2388 to 2885 498 to 1 exact     498/498
(100 %)
5 diff
(99.0 %id)
TI_154133918   .f-u 2388 to 2885 601 to 99 S23C AAA   503/1134
(44 %)
25 diff
(97.8 %id)
AI770160 2 pooled tumors (clear cell type), Kidney .f-u 2389 to 2865 487 to 10 D4C F5L K6*     478/487
(98 %)
0 diff
(100 %id)
AW009918 colon .f-u 2389 to 2886 498 to 1 exact     498/498
(100 %)
0 diff
(100 %id)
AI278004 placenta .f-u 2390 to 2887 499 to 2 exact     498/499
(99 %)
0 diff
(100 %id)
AI478170 Kidney .f-u 2394 to 2868 475 to 1 exact     475/475
(100 %)
0 diff
(100 %id)
AW083882 esophagus, squamous cell carcinoma .f-u 2394 to 2885 493 to 1 T18N L19T T20D F21I S22F ...     493/493
(100 %)
1 diff
(99.8 %id)
AW167186 serous papillary carcinoma, high grade, 2pooled tumors, uterus .f-u 2394 to 2885 492 to 1 exact     492/492
(100 %)
0 diff
(100 %id)
DB540449 hippocampus .f-u 2395 to 2885 1 to 491 S71F   Submitted on the opposite strand 491/491
(100 %)
1 diff
(99.8 %id)
BF439462 pooled .f-u 2395 to 2884 490 to 1 exact     490/490
(100 %)
1 diff
(99.8 %id)
DB542211 hippocampus .f-u 2403 to 2883 1 to 481 exact   Submitted on the opposite strand 481/483
(99 %)
1 diff
(99.8 %id)
AI283007 placenta .f-u 2405 to 2887 484 to 2 exact     483/484
(99 %)
0 diff
(100 %id)
BF589581 Prostate .f-u 2405 to 2891 487 to 1 exact     487/487
(100 %)
0 diff
(100 %id)
AA707693 pineal gland .f-u 2410 to 2887 480 to 3 exact     478/480
(99 %)
0 diff
(100 %id)
AI078346 liver and spleen .f-u 2411 to 2887 477 to 1 exact     477/477
(100 %)
0 diff
(100 %id)
BF184551 bone marrow, from chronic myelogenous leukemia .f-u 2411 to 2496 600 to 683       652/827
(78 %)
20 diff
(97.6 %id)
N59383 liver and spleen .f-u 2421 to 2885 467 to 2 I10F     466/467
(99 %)
0 diff
(100 %id)
AI126207   .f-u 2421 to 2887 468 to 2 exact     467/468
(99 %)
0 diff
(100 %id)
AW513624 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .f-u 2425 to 2887 469 to 7 exact     463/469
(98 %)
0 diff
(100 %id)
N67748 melanocyte .f-u 2433 to 2883 454 to 3 exact     452/461
(98 %)
0 diff
(100 %id)
AI679546 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .f-u 2434 to 2890 461 to 5 exact     457/461
(99 %)
0 diff
(100 %id)
AA047406 uterus .f-u 2438 to 2885 448 to 1 exact     448/450
(99 %)
1 diff
(99.8 %id)
AA937689 bowel (skin primary), metastatic melanoma to bowel .f-u 2439 to 2887 456 to 8 exact     449/456
(98 %)
0 diff
(100 %id)
N50512 multiple sclerosis lesions .f-u 2442 to 2885 452 to 1       452/453
(99 %)
11 diff
(97.6 %id)
AW102995 ovary, tumor, 5 pooled (see description) .f-u 2442 to 2887 453 to 8 exact     446/453
(98 %)
0 diff
(100 %id)
AI984753 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .f-u 2444 to 2885 441 to 1 exact     441/441
(100 %)
6 diff
(98.7 %id)
AI373915 Kidney .f-u 2450 to 2885 436 to 1 exact     436/436
(100 %)
0 diff
(100 %id)
DB538023 hippocampus .f-u 2453 to 2882 1 to 431 C11G A13P S23C L41A K42E ...   Submitted on the opposite strand 431/435
(99 %)
8 diff
(98.2 %id)
AI088753 brain, glioblastoma (pooled) .f-u 2453 to 2885 459 to 27 S23F S53F AAA   433/433
(100 %)
12 diff
(97.3 %id)
BE622070 melanotic melanoma, skin .f-u 2460 to 2880 1 to 421 exact     421/421
(100 %)
0 diff
(100 %id)
AA088722.
matches multiple genes
colon, tumor .f-u 2463 to 2887 427 to 3 exact   also hits gene STRADA 425/427
(99 %)
0 diff
(100 %id)
AI278065 placenta .f-u 2464 to 2887 425 to 2 exact     424/425
(99 %)
0 diff
(100 %id)
AW603760 colon_normal .f-u 2475 to 2770 50 to 345       296/345
(85 %)
1 diff
(99.8 %id)
AI281086 adenocarcinoma, colon .f-u 2475 to 2887 416 to 4 exact     413/416
(99 %)
0 diff
(100 %id)
DB533599 hippocampus .f-u 2480 to 2883 1 to 407 R35K T48S V49C I50H P51S ...   Submitted on the opposite strand 407/409
(99 %)
11 diff
(97.4 %id)
DB533580 hippocampus .f-u 2486 to 2885 14 to 412 T2S S3D D4V F5*   Submitted on the opposite strand 399/412
(96 %)
6 diff
(98.6 %id)
AI089934 brain, glioblastoma (pooled) .f-u 2496 to 2885 414 to 25 R35K AAA   390/390
(100 %)
5 diff
(98.8 %id)
R40078 whole brain .f-u 2498 to 2887 409 to 8 T2P S23F T24L L26F P27S ...     402/435
(92 %)
0 diff
(100 %id)
AW194761 Kidney .f-u 2502 to 2885 386 to 1 K68T F75L L76P     386/387
(99 %)
14 diff
(96.4 %id)
H28047 breast .f-u 2506 to 2886 383 to 1 V8X V14X K40X N52X K61X fully sequenced,   383/383
(100 %)
4 diff
(99.0 %id)
H92752 pineal gland .f-u 2507 to 2851 349 to 1 T2X M12X T16X Q38X Y47X ...     349/349
(100 %)
9 diff
(97.5 %id)
AI418032 Prostate .f-u 2514 to 2885 384 to 13 exact AAA   372/372
(100 %)
6 diff
(98.4 %id)
DB509313 testis .f-u 2516 to 2885 1 to 370 exact   Submitted on the opposite strand 370/370
(100 %)
1 diff
(99.8 %id)
AA320578 adipose tissue, white .f-u 2527 to 2779 1 to 253       253/258
(98 %)
1 diff
(99.7 %id)
N50443 multiple sclerosis lesions .f-u 2528 to 2886 359 to 1 exact     359/611
(58 %)
0 diff
(100 %id)
CA450350 Human Lung Epithelial cells, lung .f-u 2547 to 2885 1 to 340 exact AAA Submitted on the opposite strand 340/340
(100 %)
2 diff
(99.5 %id)
AW069428 bone marrow stroma .f-u 2549 to 2885 355 to 19 exact AAA   337/337
(100 %)
0 diff
(100 %id)
BU176354 eye, retinoblastoma .f-u 2549 to 2886 360 to 24 exact AAA Submitted on the opposite strand 337/363
(92 %)
0 diff
(100 %id)
AA934810 Kidney .f-u 2550 to 2884 335 to 1 exact     335/335
(100 %)
4 diff
(98.9 %id)
R82647 placenta .f-u 2554 to 2870 319 to 1 exact     319/319
(100 %)
2 diff
(99.4 %id)
R92461 liver and spleen .f-u 2559 to 2865 320 to 10 T2P V8X I10X I30X F46X ...     311/320
(97 %)
0 diff
(100 %id)
AA722233 pineal gland .f-u 2561 to 2887 329 to 3 exact     327/329
(99 %)
0 diff
(100 %id)
AI679985 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .f-u 2569 to 2890 326 to 5 exact     322/326
(98 %)
0 diff
(100 %id)
R60689 whole brain .f-u 2576 to 2885 322 to 12 exact AAA   311/311
(100 %)
1 diff
(99.7 %id)
AI383079 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .f-u 2590 to 2886 297 to 1 exact     297/297
(100 %)
0 diff
(100 %id)
R44445 whole brain .f-u 2602 to 2885 305 to 21 F5X I10X F21X I30X L33V ... AAA   285/285
(100 %)
1 diff
(99.7 %id)
BG941355 blood .f-u 2623 to 2887 293 to 29       265/293
(90 %)
0 diff
(100 %id)
BU735925 eye, fetal eyes .f-u 2624 to 2885 280 to 19   fully sequenced, AAA   262/262
(100 %)
0 diff
(100 %id)
AA579529   .f-u 2640 to 2885 1 to 247   AAA   247/247
(100 %)
6 diff
(97.6 %id)
AA857398 adenocarcinoma, colon .f-u 2651 to 2887 240 to 4       237/240
(98 %)
0 diff
(100 %id)
N47395 multiple sclerosis lesions .f-u 2662 to 2886 227 to 1       227/227
(100 %)
2 diff
(99.2 %id)
AA369996 Prostate .f-u 2665 to 2885 221 to 1       221/221
(100 %)
1 diff
(99.6 %id)
AL079976 uterus .f-u 2682 to 2842 204 to 44     Submitted on the opposite strand 161/204
(78 %)
0 diff
(100 %id)
AA150127 uterus .f-u 2684 to 2885 202 to 1       202/202
(100 %)
1 diff
(99.6 %id)
AI863820 2 pooled tumors (clear cell type), Kidney .f-u 2694 to 2887 197 to 4       194/197
(98 %)
0 diff
(100 %id)
FN154853 breast carcinoma .f-u 2716 to 2800 83 to 1     Submitted on the opposite strand 83/95
(87 %)
2 diff
(97.9 %id)
BQ438009 melanotic melanoma, skin .f-u 2719 to 2885 1 to 167   AAA   167/167
(100 %)
0 diff
(100 %id)
FN156784 breast carcinoma .f-u 2742 to 2823 1 to 79       79/81
(97 %)
6 diff
(92.6 %id)
DB344524 thymus .g-u 1 to 541 1 to 543 exact tiling clone, Submitted on the opposite strand 543/543
(100 %)
2 diff
(99.7 %id)
FN154774 breast carcinoma .g-u 261 to 374 1 to 113       113/113
(100 %)
1 diff
(99.2 %id)
AA293656 ovarian tumor, ovary .g-u 406 to 1000 588 to 1   tiling clone,   588/589
(99 %)
25 diff
(95.8 %id)
BI600803 brain, hypothalamus .h 1 to 862 1 to 866 exact tiling clone,   866/911
(95 %)
34 diff
(96.3 %id)
TI_45209914   .h 4 to 862 97 to 959 exact     863/1004
(85 %)
38 diff
(96.3 %id)
BE816387 breast_normal .h 83 to 528 1 to 446 Q39H     446/446
(100 %)
7 diff
(98.5 %id)
BE816422 breast_normal .h 84 to 511 1 to 430 F27L F30L L31S I33N T34N ...     430/430
(100 %)
12 diff
(97.3 %id)
CR744107 ovarian tumor, ovary .h 249 to 906 1 to 658   tiling clone, AAA   658/658
(100 %)
1 diff
(99.9 %id)
AI821580 ovarian tumor, ovary .h 410 to 907 498 to 1       498/498
(100 %)
4 diff
(99.2 %id)
BX501941 Liver .i-u 1 to 313 8 to 320 exact tiling clone,   313/320
(97 %)
6 diff
(98.2 %id)
AA852197 Bone, Hip .j-u 1 to 299 1 to 299 L2R I36V tiling clone,   299/299
(100 %)
6 diff
(98.0 %id)
AA373986 lung Gene TOMM70A, variant not shown         Suspected internal deletion, this clone was ignored    
AK302796 testis Gene TOMM70A, variant not shown         Suspected internal deletion, this clone was ignored    
BF761114 colon_est Gene TOMM70A, variant not shown         Submitted on the opposite strand    
DA457277 tongue, tumor tissue Gene TOMM70A, variant not shown       capped Suspected internal deletion, this clone was ignored    
DB317806 brain Gene TOMM70A, variant not shown              
DA533508 brain Gene TOMM70A, variant not shown       capped      
D61041   Gene TOMM70A, variant not shown         Submitted on the opposite strand    
D61191   Gene TOMM70A, variant not shown         Submitted on the opposite strand    
AV725983 hypothalamus Gene TOMM70A, variant not shown         Suspected internal deletion, this clone was ignored    
AA526089 ovary Gene TOMM70A, variant not shown              
AV745141 Pituitary Gene TOMM70A, variant not shown         This clone was ignored    
DC402667 testis Gene TOMM70A, variant not shown         Suspected internal deletion, this clone was ignored    
DB234417 trachea Gene TOMM70A, variant not shown       capped Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c-u, .d, .e, .f-u, .g-u, .h, .i-u, .j-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI